|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,473.20 INR | +0.46% |
|
+4.44% | -2.52% |
| 07-28 | Cipla Limited Receives U.S. Fda Approval for Generic Advair Diskus | CI |
| 07-24 | Jefferies Adjusts Cipla's Price Target to INR1,170 From INR1,120, Keeps at Underperform | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- CIPLA Stock
- Consensus Cipla Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
